chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got COVID; Got COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old male patient received bnt162b2 (BNT162B2), on 04Apr2021 at 16:00 as dose 1, single (Lot number: EW0151), in left arm, on 02May2021 at 16:00 as dose 2, single (Lot number: EW0167), in left arm, on 17Nov2021 at 21:00 as dose 3 (booster), single (Lot number: EJ1620), in left arm and on 21Apr2022 at 21:00 as dose 4 (booster), single (Lot number: FJ4989) at the age of 57 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Penicillin and other similar drugs, Reaction: Allergy" (unspecified if ongoing), notes: Penicillin and other similar drugs, Reaction: Allergy; "Penicillin and other similar drugs, Reaction: Allergy" (unspecified if ongoing); "Very light asthma" (unspecified if ongoing), notes: Very light asthma. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 30Aug2023, outcome "unknown" and all described as "Got COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Aug2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course details: The patient was treated with Paxlovid from 31Aug2023 to 04Sep2023 for COVID-19.
vision loss; blurred vision/retinal detachment; eye injuries; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications.  On 30-MAY-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (dose, route of administration, lot # and expiration date were not provided). Approximately in September 2017, reported as within four to five months after receiving zoster vaccine live (ZOSTAVAX), the patient suffered severe eye injuries, blurred vision, vision loss and retinal detachment resulting in extensive medical treatment and several procedures and surgeries. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and disfiguring personal injuries, emotional injuries and loss of consortium. Further, as a tragic consequence of Company's wrongful conduct, the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  The outcome of the events of severe eye injuries, vision loss and retinal detachment was reported as not recovered. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  The events of severe eye injuries, vision loss and retinal detachment were considered to be disabling. Upon internal review, the events of vision loss and retinal detachment were considered to be medically significant.
Patient had no reported side effects; expired dose of MMR-II was administered to a 4 year old patient; This spontaneous report was received from an office manager and refers to a 4-year-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 12-APR-2021, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # S005249 with expiration date on 20-FEB-2021, 0.5 milliliter, therapy type rHA (route of administration was unknown) for prophylaxis. No adverse event was reported.
Lasted 1 day :Fever, chills, sweating , lasted 2 days: migraine and jaw pain, neck pain, lightheaded, lasted 3 days: upset stomach/loss of appetite, lasted 4 days pain in arm and shoulder at injection site
MULTIPLE SCLEROSIS-FLU VACCINE IN JANUARY, AND CAME DOWN WITH MS IN MARCH-HIT ME RUNNING WENT STRAIGHT TO PROGRESSIVE-
CDC reports: 1 mo infant experienced screaming episode for more than 3 hrs following DTP/OPV immunization.
Information has been received from an RN concerning a male who was vaccinated with the 1st dose of Hep-B vaccine recombinant. Subsequently, the pt experienced fever with erythema and pain at the injection site. No further information is available.
I started feeling chills; right now still feeling chills; slight  fever; higher temperature; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 28Mar2021 11:45 (Lot Number: ENU198) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 7Mar2021 (Lot Number: EN6200) as dose 1, single for covid-19 immunisation. The patient stated that a day before reporting she took a second shot of vaccine, it was about 11:45 AM and on the day of reporting on 29Mar2021 at about 11 in the morning, she started feeling chills, slight fever and at the time of reporting still feeling chills and higher temperature. She just wanted to know was this only expected for like one day and she should be ok. The patient took Tylenol on the day of reporting as treatment. The patient had no lab work done. The outcome of the events was not recovered.  No follow up attempts are possible. No further information is expected.
10 hours after receiving vaccine, began to experience severe leg pain bilaterally. Pain increased over next 3 hours and remained constant for 2 days followed by 2 days of lesser amount of leg pain. Also at 12 hours began to experience generalized weakness and aches to entire body with temperature of 99.9. All symptoms unrelieved with Motrin or Tylenol.
She had her second Dose of COVID-19 vaccine in the afternoon.  The next morning, she was confused, had tremors in all 4 extremities, was weak, unable to bear weight, and unable to walk.  She remained in this state and bedbound for 3 days.  Her husband considered taking her to the ER but was concerned that she would be alone and unable to advocate for herself due to severe confusion.  She gradually regained strength and tremors resolved after 1-2 weeks.
No adverse event occurred. Administration error occurred - short dated batch was given to pharmacy with manufacture date of 10/21 and 12 month expiry date of 9/22, and one dose inadvertently given on 10/7/22. Manufacturer (Pfizer) was contacted and we were advised that manufacturer data supports using this specific lot of vaccines through 10/19/22 and that the dose need not be repeated.
He got the vaccine and within 15 minutes had nausea.  Today he had headache, nausea and felt like he was overheating.  He just wants to sleep.  Did not take anything for the reaction.  He is allergic to the flu vaccine and they informed the vaccination center that he was allergic and they said it was fine for him to get the vaccine.
rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE RASH (rash around the injection site). At the time of the report, VACCINATION SITE RASH (rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product were not provided/unknown. Treatment medication were not reported/unknown.
Fever (up to 100 degrees F) on and off x 3 days, severe headache for 4 hours, but the worst was the severe lower thoracic back pain that continues - with shooting sharp pains. Shoulders are achy.  Thoracic back still mildly painful to touch and feels like it is bruised but there is no discoloration, swelling or otherwise notable signs.  Also had abdominal muscle pain that felt like he was being punched in the stomach - still feels like he did a lot of sit ups.  Still having loss of appetite, loss of taste, and general fatigue.  He took Aleve once with relief of headache but no other doses have been taken.
pt recvd MMR/DTP/OPV on 12MAY88 & on 28JUN88 pt devel thrombocytopenia & was hospitalized; bone marrow exam was diagnostic for idiopathic thrombocytopenic purpura; pt recovered following tx w/steroids; MD did not feel pts exp was due to vax
Left anterolateral thigh with severe large swelling, redness, and tenderness around proximal injection site. Fever yesterday.
Patient always came down with the full blown flu within two day; Initial information received on 11-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves patient (unknown demographics) who came down with the full-blown flu within two day (influenza), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious full-blown flu (influenza), within two day following the administration of INFLUENZA VACCINE.  It was also reported that every time patient taken a flu shot that does not give other the flu, patient always came down with the full blown flu within two day.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was reported as unknown.  There will be no information available on the batch number for this case.
I started getting top left back pain in late December, that caused tingling (pins and needle sensations) up and down my left arm, all the way to my fingertips. I went to my doctor who gave me a referral to an orthopedic who sent me to physical therapy 3 times a week. I just started the physical therapy this week. I go back to see the orthopedic in a month to see if the physical therapy was successful. If not, he will order a MRI of my shoulder. Ive also began to have hot flash in my right foot that has been continuing for the last month. It lasts for about 3 seconds and then goes away.
Moderna COVID- 19 Vaccine EUA. Dose administered 1/13/21, redness, itching started 1/20/21 Redness, itching and induration. Onset 7 days after injection, located at the injection site. The erythema is about quarter size on day 8, was slightly smaller on day 7.  I had expected soreness and swelling on day 1-2 after vaccine administration, the soreness resolved. Could still feel the induration for entire week, then itching and redness started on day 7.
Patient developed urticarial rash and redness at site of injection, her throat felt like it was closing , she had difficulty  swallowing, and she experienced some heart palpitations.  Her symptoms improved without taking any medication.  She was given diphenhydramine 25 mg PO once at about 4:19 pm and prednisone 40 mg PO once at about 4:17 pm.  She was given a prescription for 2 more days of prednisone 40 mg once daily.
Around 3:50pm patient had complaint of heart jumping. Heart rate was initially 104, after 30 minutes rest, coached deep breathing, heart rate 90 regular. Patient was persistently uncomfortable and tachycardic and requested EMS evaluation. Responding EMS checked EKG, glucose, BP (etc) and released. Patient seemed to have moderate reaction to vaccine.
Tender lymphnode in the clavicle/neck region of the left side.; swollen lymphnode in the clavicle/neck region of the left side.; Tenderness below the clavicle in the chest area above the breast, below the clavicle.; swelling below the clavicle in the chest area above the breast, below the clavicle.; Pain in left side of face when I laugh or bite down; Headache on left side; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 11:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included acoustic neuroma on the left side of skull or ear. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included phendimetrazine (MANUFACTURER UNKNOWN) and salbutamol (ALBUTEROL); for an unknown indication from an unknown date and unknown if ongoing. On 15Mar2021 at 22:00, the patient experienced tender and swollen lymph node in the clavicle or neck region of the left side. Tenderness and swelling below the clavicle in the chest area above the breast, below the clavicle. Pain in left side of face when the patient laughs or bites down and headache on left side. Therapeutic measures were not taken as a result of the reported events. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tender and swollen lymph node in the clavicle/neck region of the left side. Tenderness and swelling below the clavicle in the chest area above the breast, below the clavicle. Pain in left side of face when the patient laughs or bites down and headache on left side were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
A nurse reported that a 78 year old female received an injection of Pnu-Imune 23 on 4/4/01 and subsequently, developed an injection site reaction characterized by redness, warmth, swelling and itchiness that extended from her deltoid to her forearm. The pt returned to the physician's office, 2 hours, post vax, and was treated with Benadryl. The redness, swelling and itchiness resolved. As of 4/12/01, a "small warm area" at the site of Pnu-Imune 23 administration persisted. This is 1 of 2 pts from this facility who developed an injection site reaction following receipt of Pnu-Imune 23, lot 474936.
The after getting the vaccine he had labored breathing, so I took him to the local hospital. They had him do breathing treatments for an hour, they did a chest x-ray and suctioned his nose. The mucus was very thick. They did have him hooked up to EKG leads and pulse oxygen. The doctor did say that after the breathing treatment his lungs sounded better, and the chest x-rays came back clear.
Premature Ventricular Contractions; rosacea; This is a spontaneous report from a contactable consumer(patient). A 50-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Ew0151) via an unspecified route of administration, administered in arm right on 01Apr2021 (at the age of 50-year-old) as DOSE 2, SINGLE for COVID-19 immunisation. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: unknown) via an unspecified route of administration on an unspecified date (age at vaccination 50-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history was not reported. Patient had no known drug allergies. Concomitant medications included measles vaccine, mumps vaccine, rubella vaccine (MMR) taken for an unspecified indication from 2021 to 2021 and cholecalciferol (VITAMIN D) taken for an unspecified indication, start and stop date were not reported. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested post vaccination. On an unspecified date in May2021, the patient experienced premature ventricular contractions and rosacea. It was reported that, premature ventricular contractions starting a few weeks after second vaccination, becoming worst mid-may and nearly gone by July. Also had a new case of rosacea diagnosed around the same time. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not received treatment for the events. Outcome of the event premature ventricular contractions was recovered on an unspecified date in Jul2021 and other event rosacea was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
pt recvd vax 4AUG94 in AM that nite 3AM pt began vomiting & cont to vomit 5AUG93 & low grade fever;
The vaccine was injected into my RIGHT ARM. The official record says left. I tried to contact the pharmacy records and was hung up on, disconnected, etc. There is no way to contact them to change it. Further, the location of the injection in the store was strewn with medical waste. I told the pharmacist not to kneel down on the floor because of it. I was not given any information afterwards (no aftercare, no info about adverse affects) and was not told to stay on site / sit for at least 15 minutes. They also almost lost my vax card.
I went in for an ultra sound at 20 weeks and the technician couldn't find the baby's heart beat or see the heart flicker on the screen. I had just felt the baby moving a couple days prior to my appointment and his heart beat had been 168 at my last appointment.
2 days p/receiving Td, pt collapsed @ work & hit head upon falling was told that was non responsive for @ least 30 seconds; Pt was taken to ER where MD looked @ him; CAT Scan, X-ray of skull, & bloodwork was done; Potassium level low 3.4;
I had a Pneumovax 23 vaccine 6/1/19. I got a high fever 101.7 was shivering and my arm was very sore. I went to urgent care 6/2/19. They determined it was the Pneumovax vaccine and not the Shingrix vaccine that I also received on 6/1/19. I rec'd the first Shingrix vaccine 3/30/19 with no problems. My fever went down 6/2/19 to 100.5 and I kept taking Tylenol and slept most the day and night. Today 6/3/19 I feel better and don't have a fever. I rec'd the vaccines at pharmacy. The pharmacist checked the website and stated I could receive both vaccines at the same time. Urgent care confirmed this. I have never had a bad reaction to a vaccine before other than a sore or red arm. I have a pdf of the two vaccines but not a photo. The NCD number was 00006-4837-03 for the Pneumovax 23. Rx number 6996891. The Shingrix (not the problem) was NCD 58160-0823-11, Rx number 6996890.
After 10 days the site is extremely itchy, with a red, raised circle of approx. 2.5 inches and it is hot to the touch.
nausea, sever stomach pain , dizziness, herpes outbreak, headache, muscle aches, chills, spaced out - cannot think - symptoms varied and were not all present at the same time
Pt exp depression which resolved day p/recvd 3rd vax; f/u info indicated depression occurred p/2nd dose given MAR90;
Tachycardia; Drowsiness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Tachycardia) and SOMNOLENCE (Drowsiness) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced TACHYCARDIA (Tachycardia) and SOMNOLENCE (Drowsiness). On 05-Feb-2021, TACHYCARDIA (Tachycardia) and SOMNOLENCE (Drowsiness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Extremely sore upper left arm near the joint  between arm & shoulder. Unable to lift arm at shoulder. Only able to bend arm at elbow. Pain mainly radiates from injection site. Left arm totally useless without incurring extreme pain DTaP was given in response to cutting my thumb on a piece of metal. Cut was cleaned and closed at Hospital ER (with steri strips)
Extra dose administered; Was weak; Barely could walk; She felt like she was going to pass out; Had aches; Was shaky; This case was reported by a nurse via sales rep and described the occurrence of weakness in a adolescent female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis.   Previously administered products included Menveo (received 1st dose in 2015) and Menveo (received booster dose in July 2019).   In August 2019, the patient received Bexsero and the 3rd dose of Menveo. In August 2019, less than a month after receiving Bexsero and Menveo, the patient experienced weakness, walking difficulty, felt faint, pain and tremor. On an unknown date, the patient experienced extra dose administered. On an unknown date, the outcome of the weakness, walking difficulty, felt faint, pain, tremor and extra dose administered were unknown.   It was unknown if the reporter considered the weakness, walking difficulty, felt faint, pain and tremor to be related to Bexsero and Menveo.  Additional case details were reported as follows: The age at vaccination was not reported. The patient accidentally received a 3rd dose in August 2019 (co-administration with Bexsero).  The patients was so weak and barely could walk a couple days after administration. The patient went to emergency room.  She felt like she was going to pass out and had aches, and was shaky. The reporter denied permission to follow up.
At 1520 staff was notified by another patient in the court yard that patient not feeling well; assessed patient- noted to be  nauseated was orient to person and time; not oriented to place. Denies chest pain/SOB/tightening  of throat/ voice is unchanged./ breathing well  1525 VS checked; 140-92  1526O   O2 saturationa uration noted to be 97%; noted to orients to person, place and time now (pt stated he has history of getting dizzy and dalmost   fainting after blood draws) 1531 Patient verbalizes that he is feels better 11538  Patient stable for dis charge
Periorbital edema, hives throughout body,  eventually feeling of throat swelling. Started at 3am with one eyelid itching , swelling and throughout the day second eye began itching and swelling. Hives appeared in multiple places all over and by 8pm throat began to feel as if it was swelling-couldn?t swallow well and at that time went to the ER. Was treated with Epi. Benadryl. Pepcid and solu medrol, monitored and eventually discharged home with 5 days of prednisone and epi pen for any further reaction.